|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
2 August 2023 |
|
Main ID: |
NCT03169166 |
|
Date of registration:
|
25/05/2017 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
The Use of GnRH Agonist Trigger for Final Follicle Maturation in Women Undergoing Assisted Reproductive Technologies
|
|
Scientific title:
|
The Use of GnRH Agonist Trigger for Final Follicle Maturation in Women Undergoing Assisted Reproductive Technologies: A Prospective Randomized Controlled Trial |
|
Date of first enrolment:
|
March 1, 2017 |
|
Target sample size:
|
277 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/ct2/show/NCT03169166 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
|
|
Phase:
|
Phase 4
|
|
|
Countries of recruitment
|
|
Lebanon
| | | | | | | |
|
Contacts
|
|
Name:
|
Johnny Awwad, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
American University of Beirut Medical Center |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Normal uterine cavity (as assessed by hysteroscopy or HSG).
- Normal hormonal investigation: TSH, PRL.
- More than 15 follicles (=12 mm in diameter) on ultrasound, and/or estradiol level of >
3500 pg/ml on the day of trigger.
Exclusion Criteria:
- History of three or more miscarriages.
- History of three or more previous IVF failures.
- Abnormal uterine cavity (Hysteroscopy or HSG).
Age minimum:
18 Years
Age maximum:
40 Years
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Sterility
|
|
Infertility
|
|
Intervention(s)
|
|
Drug: Triptorelin
|
|
Primary Outcome(s)
|
|
Ongoing pregnancy rate in hyper-responder women undergoing assisted reproductive technology cycles
[Time Frame: 20 weeks from Last Menstrual Period (LMP)]
|
|
Secondary Outcome(s)
|
|
Oocyte collection rate
[Time Frame: On the day of ovum pick-up]
|
|
Secondary ID(s)
|
|
AmericanUBMCGNRH
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|